Bh Group Us, LLC appears in FDA 510(k) records as the applicant for K243223, a Class 2 device filed under product code PBX and regulation 21 CFR 878.4400, with a decision of substantially equivalent dated September 22, 2026. The submission was received October 7, 2024, reviewed as a Traditional 510(k) by the General, Plastic Surgery panel, and carried a summary rather than a statement. Third-party review was not used. The record identifies the device as a multiple therapy aesthetic treatment device under the name BHS 202 UNYQUE. [1][3][4]
The documented filing
K243223 is the only 510(k) record linked to Bh Group Us, LLC in the collected filings, and its decision code is SESE, meaning substantially equivalent. The device is classified as a massager, vacuum, radio frequency induced heat device in Class 2, with the advisory committee listed as General, Plastic Surgery. The filing address on record is in Davie, Florida; that address is a filing detail and does not establish a headquarters. [1][3][6]
The FDA record lists the applicant contact as Diego Bazzurro and gives the device name as Multiple therapy aesthetic treatment device (BHS 202 UNYQUE). The clearance type is Traditional, the third-party flag is N, and the statement or summary field reads Summary. [1][3]
Technology and predicate comparison
A technological comparison section states that all devices deliver radiofrequency energy to biological tissue to achieve controlled heating for therapeutic or aesthetic purposes. The intended-use discussion describes treatment of selected medical conditions including pain relief, reduction of muscle spasms, enhancement of local blood circulation, and temporary improvement in the appearance of cellulite. [4][5]
The comparison names two predicate devices: the Sectum System (K202780) and the Viora V10 (K150035). The filing discusses their listed indications as part of its substantial-equivalence comparison. The individual FDA records remain the sources for the specific scope of each predicate’s clearance. [4][5]
What the record does not establish
The collected filings do not identify a parent company, brand owner, website, customer base, or commercial availability for Bh Group Us, LLC. No recall records appear in the collected sample. The single clearance is a count of linked filings at the snapshot date, not a measure of total portfolio, sales, or safety performance. [1][6]
An independent tracker covering product code PBX and related aesthetic codes reports 152 clearances and 34 recall records across those codes since November 15, 2024, with its latest clearance dated October 26, 2026. That page describes itself as unaffiliated with any device manufacturer and notes that new decisions can take several weeks to appear. [7]
Context within product code PBX
Other PBX records listed alongside K243223 include K252288 for a TECAR Therapy Device (TC2000, TC2001) from Shenzhen Dongdixin Technology Co., Ltd., decided October 13, 2026, and K243164 for INDIBA COMPACT devices from Indiba S. A. U., decided November 20, 2024. These entries show the code's use by multiple applicants. [3]
The FDA 510(k) database page for K243223 was last updated October 26, 2026, and shows no change control plan authorized. The device remains a Class 2 aesthetic and therapeutic radiofrequency system in the public record. [2][4]
